等待开盘 04-03 09:30:00 美东时间
+0.160
+11.19%
今日重点评级关注:Freedom Capital Markets:维持LifeMD"买入"评级,目标价从8美元升至10美元;Chardan Capital:维持Opus Genetics"买入"评级,目标价从9美元升至11美元
03-13 09:59
TD Cowen analyst Jonna Kim maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $3 to $2.5.
03-13 00:48
Biote (NASDAQ:BTMD) sees FY2026 sales of $190.000 million vs $196.193 million analyst estimate.
03-12 04:10
Companies Reporting Before The Bell • Sprinklr (NYSE:CXM) is estimated to repor...
03-11 19:11
On January 26, 2026, F.H. Investments, Inc. ("Asteria Health"), a 503B manufacturer of compounded bioidentical hormones and wholly-owned subsidiary of biote Corp. (the "Company"), out of an abundance of caution initiated
01-27 06:27
Biote (NASDAQ:BTMD) affirms FY2025 sales outlook from $190.000 million to $190.000 million vs $192.670 million estimate.
2025-11-06 05:19
Biote (NASDAQ:BTMD) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29 percent. This is a 33.33 percent decrease over earnings of $0.33 per share from the same
2025-11-06 05:19
Biote shares are trading lower after the company reported mixed Q2 financial re...
2025-08-07 05:33
biote ( ($BTMD) ) just unveiled an update. On June 2, 2025, Steven J. Heyer res...
2025-06-05 20:46
Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 10.9% to $0.67 durin...
2025-05-28 05:06